Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Evaluation of Soluble Epoxide Hydrolase (s-EH) Inhibitor in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance

ClinicalTrials.gov ID: NCT00847899

Public ClinicalTrials.gov record NCT00847899. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Exploratory, 28-Day Study to Examine the Effects of AR9281 on Blood Pressure and Glucose Tolerance in Patients With Mild to Moderate Hypertension and Impaired Glucose Tolerance

Study identification

NCT ID
NCT00847899
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Arete Therapeutics
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • AR9281 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2008
Primary completion
Sep 30, 2009
Completion
Oct 31, 2009
Last update posted
Nov 19, 2009

2009

United States locations

U.S. sites
30
U.S. states
14
U.S. cities
29
Facility City State ZIP Site status
Arete Investigational site Mobile Alabama 36617
Arete Investigational site Muscle Shoals Alabama 35662
Arete Investigational site Anaheim California 92801
Arete Investigational site Concord California 94520
Arete Investigational site Mission Hills California 91345
Arete Investigational site Bradenton Florida 34203
Arete Investigational site DeLand Florida 32720
Arete Investigational site Jacksonville Florida 32216
Arete Investigational site Largo Florida 33770
Arete Investigational site Miami Florida 33169
Arete Investigational site New Port Richey Florida 34652
Arete Investigational site Pembroke Pines Florida 33026
Arete Investigational site Port Orange Florida 32127
Arete Investigational site Tampa Florida 33606
Arete Investigational site Marietta Georgia 30066
Arete Investigational site Addison Illinois 60101
Arete Investigational site Louisville Kentucky 40213
Arete Investigational site Brockton Massachusetts 02301
Arete Investigational site Paw Paw Michigan 49079
Arete Investigational site Las Vegas Nevada 89123
Arete Investigational site Cincinnati Ohio 45219
Arete Investigational site Cincinnati Ohio 45245
Arete Investigational site Marion Ohio 43302
Arete investigational site Mount Gilead Ohio 43338
Arete Investigational site Oklahoma City Oklahoma 73132
Arete Investigational site Eugene Oregon 97404
Arete Investigational site Austin Texas 78704
Arete Investigational site Dallas Texas 75251
Arete Investigational site San Antonio Texas 78229
Arete Investigational site Orem Utah 84058

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00847899, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 19, 2009 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00847899 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →